Dynamic cost-effective reduction strategies for acidification in Europe: An application to ireland and the United Kingdom

被引:1
|
作者
Schmieman, E
de Vries, W
Hordijk, L
Kroeze, C
Posch, M
Reinds, GJ
van Ierland, E
机构
[1] Minist Econ Affairs, Econ Policy Directorate AEP, NL-2500 EC The Hague, Netherlands
[2] Alterra, NL-6700 AA Wageningen, Netherlands
[3] Univ Wageningen & Res Ctr, Dept Environm Sci, Environm Syst Anal Grp, NL-6700 HB Wageningen, Netherlands
[4] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands
[5] Univ Wageningen & Res Ctr, Environm Econ & Nat Resources Grp, NL-6700 EW Wageningen, Netherlands
关键词
environmental economics; cost-effectiveness; dynamic soil acidification; Europe; integrated assessment; modelling; transboundary;
D O I
10.1023/A:1016376705496
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
This paper describes the application of an optimisation model for calculating cost-effective abatement strategies for the reduction of acidification in Europe while taking into account the dynamic character of soil acidification in a number of countries. Environmental constraints are defined in terms of soil quality indicators, e.g., pH, base saturation or the aluminium ion concentration in the soil solution within an optimisation model for transboundary air pollution. We present a case study for Ireland and the United Kingdom. Our results indicate that reduction of sulphur dioxide emission is more cost-effective than that of nitrogen oxides or ammonia. The reduction percentages for sulphur dioxide are highest, for two reasons: (i) marginal sulphur dioxide reduction costs are relatively low compared to marginal reduction costs of nitrogen oxides and ammonia and (ii) sulphur dioxide reduction is more effective in reducing acidification in physical terms than nitrogen oxides or ammonia abatement. Our dynamic analysis shows that a (fast) improvement of soil quality requires high emission reduction levels. These reduction levels are often higher than reduction levels that are typically deduced from the static critical loads approach. Once soil quality targets are reached, in our model, less stringent emission reductions are required to maintain the soil quality at a constant and "good" target level. Static critical load approaches that ignore dynamic aspects therefore may underestimate the emission reductions needed to achieve predefined soil quality targets.
引用
收藏
页码:163 / 178
页数:16
相关论文
共 50 条
  • [41] Cost-Effective Dynamic Control for Transmission Systems
    Jinsiwale, Rohit
    Mauger, Mickael J.
    Kandula, R. P.
    Divan, Deepak
    Jaroszewski, Marion
    Schatz, Joe
    CONFERENCE RECORD OF THE THIRD IEEE INTERNATIONAL WORKSHOP ON ELECTRONIC POWER GRID (EGRID), 2018, : 95 - 100
  • [42] Dynamic Cost-effective Emergency Network Provision
    Sriramulu, Roop K.
    Park, Younghee
    Chang, Sang-Yoon
    Liu, Kaikai
    PROCEEDINGS OF THE 2017 FIRST CONEXT WORKSHOP ON ICT TOOLS FOR EMERGENCY NETWORKS AND DISASTER RELIEF (I-TENDER '17), 2017, : 37 - 43
  • [43] Inflammatory Bowel Disease-Attributable Costs and Cost-effective Strategies in the United States: A Review
    Park, K. T.
    Bass, Dorsey
    INFLAMMATORY BOWEL DISEASES, 2011, 17 (07) : 1603 - 1609
  • [44] Once-Weekly Subcutaneous Semaglutide 2.4 mg Injection is Cost-Effective for Weight Management in the United Kingdom
    Hera Sandhu
    Weiwei Xu
    Anamaria-Vera Olivieri
    Christopher Lübker
    Inger Smith
    Vasileios Antavalis
    Advances in Therapy, 2023, 40 : 1282 - 1291
  • [45] RULING OUT IBD IN THE UNITED KINGDOM AND BRAZIL: IS THE USAGE OF F-CALPROTECTIN IN PRIMARY CARE COST-EFFECTIVE?
    Mascialino, B.
    Hermansson, L. L.
    Larsson, A.
    VALUE IN HEALTH, 2013, 16 (07) : A692 - A692
  • [46] Once-Weekly Subcutaneous Semaglutide 2.4 mg Injection is Cost-Effective for Weight Management in the United Kingdom
    Sandhu, Hera
    Xu, Weiwei
    Olivieri, Anamaria-Vera
    Lubker, Christopher
    Smith, Inger
    Antavalis, Vasileios
    ADVANCES IN THERAPY, 2023, 40 (03) : 1282 - 1291
  • [47] Is scorpion antivenom cost-effective as marketed in the United States?
    Armstrong, Edward P.
    Bakall, Maja
    Skrepnek, Grant H.
    Boyer, Leslie V.
    TOXICON, 2013, 76 : 394 - 398
  • [48] Are glycoprotein IIb/IIIa antagonists cost-effective in acute coronary syndromes: Potential impact of tirofiban in the United Kingdom
    Bakhai, A
    Flather, M
    Collinson, J
    Stevens, W
    Normand, C
    Ward, B
    Ben-Joseph, R
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) : 507A - 507A
  • [49] Predicting Food-Safety Risk and Determining Cost-Effective Risk-Reduction Strategies
    Nganje, William E.
    Burbidge, Linda D.
    Denkyirah, Elisha K.
    Ndembe, Elvis M.
    JOURNAL OF RISK AND FINANCIAL MANAGEMENT, 2021, 14 (09)
  • [50] RULING OUT IBD IN THE UNITED KINGDOM AND SPAIN: IS THE USAGE OF F-CALPROTECTIN IN PRIMARY CARE COST-EFFECTIVE?
    Mascialino, B.
    Hermansson, L. L.
    Larsson, A.
    VALUE IN HEALTH, 2013, 16 (07) : A493 - A493